Company Update (NASDAQ:CELG): Celgene Reports Third Quarter 2015 Operating and Financial Results

[Business Wire] – Celgene Corporation reported net product sales of $2,313 million for the third quarter of 2015, an 18 percent increase from the same period in 2014. The negative net impact of . . . → Read More: Company Update (NASDAQ:CELG): Celgene Reports Third Quarter 2015 Operating and Financial Results Similar Articles: Company Update (NASDAQ:CELG): Robbins Arroyo LLP: Acquisition of Receptos, Inc. (RCPT) by Celgene Corporation (CELG) May Not Be in Shareholders’ Best Interests Market Update: Celgene Corporation (NASDAQ:CELG) – Celgene Corporation to Webcast at Upcoming Investor Conferences in June Company Update (NASDAQ:CELG): Celgene Announces Presentations of Investigational Studies in Solid Tumor and Blood Cancers at ASCO 2015